Eupatorin is widely studied for its anti-inflammatory and anticancer properties. It has shown potential in inhibiting the growth of various cancer cell lines, particularly in breast, colon, and liver cancers, by inducing apoptosis and blocking cell cycle progression. Its ability to modulate key signaling pathways such as PI3K/AKT and MAPK makes it a candidate for cancer therapy research.

It also exhibits neuroprotective effects, suggesting possible use in treating neurodegenerative disorders like Alzheimer’s disease. Additionally, eupatorin demonstrates antioxidant activity, helping reduce oxidative stress in cells.

In traditional medicine, compounds containing eupatorin are used to treat respiratory and liver conditions, and modern research supports its role in reducing airway inflammation, indicating potential application in asthma or allergic rhinitis treatment.

Due to its natural origin and low toxicity profile, eupatorin is being explored as a lead compound for developing safer therapeutic agents in oncology and inflammatory diseases.